Osamu Kawai

470 citations
10 papers · 374 indexed · h-index 7

Osamu Kawai

8 papers receiving 367 citations

Peers

Osamu Kawai
Comparison fields: 5 of 48
  • Immunology 235
  • Oncology 288
  • Pulmonary and Respiratory Medicine 82
  • Cancer Research 34
  • Otorhinolaryngology 5
Replace Claudia Röefzaad with:
Claudia Röefzaad Germany
Wolfgang Moersig Germany
M.A. Vicente Conesa Spain
Hideo Omata Japan
Stefania Laurent Italy
Giuseppe Cipollone Italy
Amy Sullivan United States
Carla Costa-Nunes Switzerland
Yuki Muroyama United States
C. Zingaretti Italy
Osamu Kawai relative to Claudia Röefzaad Germany Claudia Röefzaad's profile →
Citations per field
00.5×1.5×2.5×
Claudia Röefzaad · 1×
Citations per year

Countries citing papers authored by Osamu Kawai

Since Specialization
Citations

This map shows the geographic impact of Osamu Kawai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Kawai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Kawai more than expected).

Fields of papers citing papers by Osamu Kawai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Kawai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Kawai. The network helps show where Osamu Kawai may publish in the future.

Co-authorship network

The 23 scholars most cited alongside Osamu Kawai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Osamu Kawai Line = papers co-authored together Osamu Kawai links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 20232
2
[Psoriasis and Psoriatic Arthritis Induced by Nivolumab in a Patient with Advanced Non-Small-Cell Lung Cancer].
20177
3 20160
4 20137
5 20138
6 20090
7 2008312
8 200814
9 200714
10 200710

About Osamu Kawai

Osamu Kawai is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Oral Surgery, Rheumatology and Pharmacology, having authored 10 papers that have together received 374 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers), Pneumothorax, Barotrauma, Emphysema (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Oral and Maxillofacial Pathology (1 paper). The work is most often cited by research in Immunology (235 citations), Oncology (288 citations), Pulmonary and Respiratory Medicine (82 citations), Cancer Research (34 citations) and Otorhinolaryngology (5 citations). Osamu Kawai has collaborated with scholars based in Japan and United States. Frequent co-authors include Atsushi Ochiai, Yoichi Naito, Keiju Aokage, Tetsuya Mizuno, Genichiro Ishii, Yutaka Nishiwaki, Yukinori Murata, Akihiko Gemma, Nagahiro Saijo and Kaoru Kubota. Their work appears in journals such as Cancer, Journal of Thoracic and Cardiovascular Surgery, SpringerPlus, Lung Cancer and Pathology International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026